Bausch Health Companies reported $993M in EBIT for its fiscal quarter ending in September of 2026.





Ebit Change Date
Amgen USD 4.68B 65M Sep/2026
ANI Pharmaceuticals USD 51.84M 12M Sep/2026
Aurora Cannabis CAD -3.17M 10.29M Jun/2026
Bausch Health Companies USD 993M 217M Sep/2026
Biogen USD 419.5M 663.3M Sep/2026
Bristol-Myers Squibb USD 255M 44M Sep/2026
Canopy Growth CAD -2.03M 143.62M Jun/2026
Corcept Therapeutics USD 114.72M 73.42M Sep/2026
Danaher USD 1.25B 118M Sep/2026
Drreddys Laboratories INR 13.52B 10.47B Sep/2026
Eli Lilly USD 13.09B 635M Sep/2026
Gilead Sciences USD 3.85B 1.17B Jun/2026
Nektar Therapeutics USD -38.26M 19.17M Mar/2026
Novo Nordisk DKK 33.76B 25.86B Jun/2026
Pacira USD 2.57B 2.56B Sep/2026
Perrigo USD 27.2M 116.6M Sep/2026
Phibro Animal Health USD 54.99M 2.36M Dec/2025
Prestige Brands USD 52.52M 22.97M Jun/2026
Supernus Pharmaceuticals USD -21.04M 14.21M Jun/2026
Vertex Pharmaceuticals USD 1.26B 11.3M Sep/2026
Zoetis USD 1.03B 88M Sep/2026